Candel Therapeutics CADL
NASDAQ CADL
$10.44 -0.44 (-4.04%)
At close: Sep 30, 2026 · 4:00 PM EDT

Candel Therapeutics (CADL) Asset Utilization Ratio (2021 - 2022)

Updated

Candel Therapeutics' (CADL) Asset Utilization Ratio stood at 0.00 in Q4 2022, up 13.8% from 0.00 a year earlier and up 9.6% from the prior quarter.

Analysis

Candel Therapeutics (CADL) Asset Utilization Ratio (2021 - 2022) Analysis & Trends

Starting with Q3 2021, Candel Therapeutics' Asset Utilization Ratio history includes 6 quarters.

  • Across earlier years, Asset Utilization Ratio came in at 0.00 in FY2021.
  • The Q4 2022 figure is the highest quarterly Asset Utilization Ratio since Q3 2021.
  • Per Business Quant, the preceding three quarters came in at 0.00 (Q3 2022), 0.00 (Q2 2022) and 0.00 (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 0.49
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 0.47
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 0.52
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 0.44
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 0.53
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 0.40
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 0.58
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 0.47
10 Candel Therapeutics 794.67 Mn 794.67 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 0.00
Sep 30, 2022 0.00
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Dec 31, 2021 0.00
Sep 30, 2021 0.00
API Access

Candel Therapeutics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=CADL&period=max&api_key=YOUR_API_KEY